Case Report: COVID-19 Recovery from Triple Infection with <i>Mycobacterium tuberculosis</i>, HIV, and SARS-CoV-2
Rivas N, Espinoza M, Loban A, Luque O, Jurado J, Henry-Hurtado N, Goodridge A
The American journal of tropical medicine and hygiene · 2020-10
Abstract
COVID-19, designated as SARS-CoV-2, has caused millions of infections worldwide, including in patients with concomitant infections. Here, we report two unusual cases of patients with triple infections of SARS-CoV-2, Mycobacterium tuberculosis , and HIV. Both cases were confirmed through microbiological and immunological studies. The acute respiratory phase in both patients was treated with supplemental oxygen. Antituberculosis and antiretroviral therapies were started simultaneously. In 2 weeks, both patients demonstrated clinical improvement and recovery from COVID-19. Our findings suggest that even in cases of triple infection, clinical management together with respiratory therapy contributes to patient survival.
MeSH terms
- Humans
- Mycobacterium tuberculosis
- HIV
- Tuberculosis, Pulmonary
- Pneumonia, Viral
- Coronavirus Infections
- HIV Infections
- Convalescence
- Hydroxychloroquine
- Heparin
- Antitubercular Agents
- Antiviral Agents
- Positive-Pressure Respiration
- Adult
- Middle Aged
- Male
- Pandemics
- Coinfection
- Betacoronavirus
- COVID-19
- SARS-CoV-2